
Loading, please wait...

Loading, please wait...

The study by Shah D et al. highlights a novel metabolic dependency that regulates fungal morphological plasticity and virulence in Candida albicans. Fungi utilize their ability to switch between yeast and hyphal forms to survive in various ecological environments. This transition serves as a critical hallmark of their pathogenicity in humans. Historically, researchers focused primarily on gene regulatory networks to explain these changes. However, this recent study identifies glycolysis as a primary driver of sulfur-containing amino acid biosynthesis. Consequently, this metabolic coupling is essential for the physical transitions observed in invasive fungal species.
The researchers used a multidisciplinary approach to demonstrate that glycolytic flux drives the yeast-to-hyphal transition. This process occurs through a cAMP-independent pathway. Specifically, when the glycolytic pathway is inhibited, the expression of genes involved in sulfur metabolism decreases significantly. Interestingly, external supplementation of sulfur-containing amino acids can rescue these morphological defects. This finding confirms that sulfur metabolism acts as a downstream effector of the glycolytic process. In addition, the conversion of carbon sources to amino acids facilitates the structural changes needed for tissue invasion.
The study specifically examined Candida albicans, a major opportunistic pathogen in hospital settings. A mutant lacking the glycolytic enzyme phosphofructokinase-1 (Pfk1) exhibited reduced survival within murine macrophages. Furthermore, these mutants showed attenuated virulence in models of systemic candidiasis. These findings suggest that targeting the link between carbon and sulfur metabolism could lead to new antifungal strategies. Understanding these metabolic constraints provides insight into how fungi adapt to the host environment during systemic dissemination.
Fungal morphogenesis allows pathogens like Candida albicans to change their shape, which helps them invade deep tissues and evade the host immune system.
Glycolysis provides the necessary metabolic flux to produce sulfur-containing amino acids, which are critical for the structural transitions that make fungi more virulent.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Shah D et al. Glycolysis-dependent sulfur metabolism orchestrates morphological plasticity and virulence in fungi. Elife. 2026 Feb 06. doi: undefined. PMID: 41649875.
Talapko J et al. Candida albicans—The Virulence Factors and Clinical Manifestations of Infection. J Fungi. 2021;7(2):79.
Huang G. Regulation of phenotypic transitions in the fungal pathogen Candida albicans. Virulence. 2012;3(1):3-7.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research identifies a conserved link between glycolysis and sulfur metabolism that drives fungal morphogenesis and virulence in Candida albicans....
8 months ago

Discover the crucial role of glymphatic dysfunction in stroke, where perivascular clearance failure and neuroinflammation exacerbate cerebral edema and post-stroke brain injury.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday